APO RESEARCH · REPORT
Plasma Fractionation
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Product & engineering
Understand the product.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Selected research
Market Analysis & Forecast
Global Plasma Fractionation Market Analysis and Forecast 2026-2032
Market perspective
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
Read the full market overview
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
This report presents an overview of global market for Plasma Fractionation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Plasma Fractionation, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma Fractionation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Fractionation sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Fractionation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Plasma Fractionation sales, projected growth trends, production technology, application and end-user industry.
Plasma Fractionation Segment by Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Plasma Fractionation Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Others
Plasma Fractionation Segment by Application
Immunology
Hematology
Others
Plasma Fractionation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Plasma Fractionation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fractionation sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
Applications
- Immunology
- Hematology
- Others
Companies covered
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Plasma Fractionation Market by Type
- 1.2.1 Global Plasma Fractionation Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Albumin
- 1.2.3 Immune Globulin
- 1.2.4 Coagulation Factor
- 1.2.5 Others
- 1.3 Plasma Fractionation Market by Application
- 1.3.1 Global Plasma Fractionation Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Immunology
- 1.3.3 Hematology
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasma Fractionation Market Dynamics
- 2.1 Plasma Fractionation Industry Trends
- 2.2 Plasma Fractionation Industry Drivers
- 2.3 Plasma Fractionation Industry Opportunities and Challenges
- 2.4 Plasma Fractionation Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Plasma Fractionation Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Plasma Fractionation Revenue by Region
- 3.2.1 Global Plasma Fractionation Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Plasma Fractionation Revenue by Region (2021-2026)
- 3.2.3 Global Plasma Fractionation Revenue by Region (2027-2032)
- 3.2.4 Global Plasma Fractionation Revenue Market Share by Region (2021-2032)
- 3.3 Global Plasma Fractionation Sales Estimates and Forecasts 2021-2032
- 3.4 Global Plasma Fractionation Sales by Region
- 3.4.1 Global Plasma Fractionation Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Plasma Fractionation Sales by Region (2021-2026)
- 3.4.3 Global Plasma Fractionation Sales by Region (2027-2032)
- 3.4.4 Global Plasma Fractionation Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Plasma Fractionation Revenue by Manufacturers
- 4.1.1 Global Plasma Fractionation Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Plasma Fractionation Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Plasma Fractionation Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Plasma Fractionation Sales by Manufacturers
- 4.2.1 Global Plasma Fractionation Sales by Manufacturers (2021-2026)
- 4.2.2 Global Plasma Fractionation Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Plasma Fractionation Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Plasma Fractionation Sales Price by Manufacturers (2021-2026)
- 4.4 Global Plasma Fractionation Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Plasma Fractionation Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Plasma Fractionation Manufacturers, Product Type & Application
- 4.7 Global Plasma Fractionation Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Plasma Fractionation Market CR5 and HHI
- 4.8.2 2025 Plasma Fractionation Tier 1, Tier 2, and Tier 3
5 Plasma Fractionation Market by Type
- 5.1 Global Plasma Fractionation Revenue by Type
- 5.1.1 Global Plasma Fractionation Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Plasma Fractionation Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Plasma Fractionation Revenue Market Share by Type (2021-2032)
- 5.2 Global Plasma Fractionation Sales by Type
- 5.2.1 Global Plasma Fractionation Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasma Fractionation Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Plasma Fractionation Sales Market Share by Type (2021-2032)
- 5.3 Global Plasma Fractionation Price by Type
6 Plasma Fractionation Market by Application
- 6.1 Global Plasma Fractionation Revenue by Application
- 6.1.1 Global Plasma Fractionation Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Plasma Fractionation Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Plasma Fractionation Revenue Market Share by Application (2021-2032)
- 6.2 Global Plasma Fractionation Sales by Application
- 6.2.1 Global Plasma Fractionation Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Plasma Fractionation Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Plasma Fractionation Sales Market Share by Application (2021-2032)
- 6.3 Global Plasma Fractionation Price by Application
7 Company Profiles
- 7.1 Takeda
- 7.1.1 Takeda Company Information
- 7.1.2 Takeda Business Overview
- 7.1.3 Takeda Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Takeda Plasma Fractionation Product Portfolio
- 7.1.5 Takeda Recent Developments
- 7.2 CSL
- 7.2.1 CSL Company Information
- 7.2.2 CSL Business Overview
- 7.2.3 CSL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 CSL Plasma Fractionation Product Portfolio
- 7.2.5 CSL Recent Developments
- 7.3 Grifols
- 7.3.1 Grifols Company Information
- 7.3.2 Grifols Business Overview
- 7.3.3 Grifols Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Grifols Plasma Fractionation Product Portfolio
- 7.3.5 Grifols Recent Developments
- 7.4 Octapharma
- 7.4.1 Octapharma Company Information
- 7.4.2 Octapharma Business Overview
- 7.4.3 Octapharma Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Octapharma Plasma Fractionation Product Portfolio
- 7.4.5 Octapharma Recent Developments
- 7.5 Kedrion
- 7.5.1 Kedrion Company Information
- 7.5.2 Kedrion Business Overview
- 7.5.3 Kedrion Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Kedrion Plasma Fractionation Product Portfolio
- 7.5.5 Kedrion Recent Developments
- 7.6 LFB Group
- 7.6.1 LFB Group Company Information
- 7.6.2 LFB Group Business Overview
- 7.6.3 LFB Group Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 LFB Group Plasma Fractionation Product Portfolio
- 7.6.5 LFB Group Recent Developments
- 7.7 Biotest
- 7.7.1 Biotest Company Information
- 7.7.2 Biotest Business Overview
- 7.7.3 Biotest Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Biotest Plasma Fractionation Product Portfolio
- 7.7.5 Biotest Recent Developments
- 7.8 BPL
- 7.8.1 BPL Company Information
- 7.8.2 BPL Business Overview
- 7.8.3 BPL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 BPL Plasma Fractionation Product Portfolio
- 7.8.5 BPL Recent Developments
- 7.9 RAAS
- 7.9.1 RAAS Company Information
- 7.9.2 RAAS Business Overview
- 7.9.3 RAAS Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 RAAS Plasma Fractionation Product Portfolio
- 7.9.5 RAAS Recent Developments
- 7.10 CBPO
- 7.10.1 CBPO Company Information
- 7.10.2 CBPO Business Overview
- 7.10.3 CBPO Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 CBPO Plasma Fractionation Product Portfolio
- 7.10.5 CBPO Recent Developments
- 7.11 Hualan Bio
- 7.11.1 Hualan Bio Company Information
- 7.11.2 Hualan Bio Business Overview
- 7.11.3 Hualan Bio Plasma Fractionation Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Hualan Bio Plasma Fractionation Product Portfolio
- 7.11.5 Hualan Bio Recent Developments
8 North America
- 8.1 North America Plasma Fractionation Market Size by Type
- 8.1.1 North America Plasma Fractionation Revenue by Type (2021-2032)
- 8.1.2 North America Plasma Fractionation Sales by Type (2021-2032)
- 8.1.3 North America Plasma Fractionation Price by Type (2021-2032)
- 8.2 North America Plasma Fractionation Market Size by Application
- 8.2.1 North America Plasma Fractionation Revenue by Application (2021-2032)
- 8.2.2 North America Plasma Fractionation Sales by Application (2021-2032)
- 8.2.3 North America Plasma Fractionation Price by Application (2021-2032)
- 8.3 North America Plasma Fractionation Market Size by Country
- 8.3.1 North America Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Plasma Fractionation Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Plasma Fractionation Market Size by Type
- 9.1.1 Europe Plasma Fractionation Revenue by Type (2021-2032)
- 9.1.2 Europe Plasma Fractionation Sales by Type (2021-2032)
- 9.1.3 Europe Plasma Fractionation Price by Type (2021-2032)
- 9.2 Europe Plasma Fractionation Market Size by Application
- 9.2.1 Europe Plasma Fractionation Revenue by Application (2021-2032)
- 9.2.2 Europe Plasma Fractionation Sales by Application (2021-2032)
- 9.2.3 Europe Plasma Fractionation Price by Application (2021-2032)
- 9.3 Europe Plasma Fractionation Market Size by Country
- 9.3.1 Europe Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Plasma Fractionation Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Plasma Fractionation Market Size by Type
- 10.1.1 China Plasma Fractionation Revenue by Type (2021-2032)
- 10.1.2 China Plasma Fractionation Sales by Type (2021-2032)
- 10.1.3 China Plasma Fractionation Price by Type (2021-2032)
- 10.2 China Plasma Fractionation Market Size by Application
- 10.2.1 China Plasma Fractionation Revenue by Application (2021-2032)
- 10.2.2 China Plasma Fractionation Sales by Application (2021-2032)
- 10.2.3 China Plasma Fractionation Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Plasma Fractionation Market Size by Type
- 11.1.1 Asia Plasma Fractionation Revenue by Type (2021-2032)
- 11.1.2 Asia Plasma Fractionation Sales by Type (2021-2032)
- 11.1.3 Asia Plasma Fractionation Price by Type (2021-2032)
- 11.2 Asia Plasma Fractionation Market Size by Application
- 11.2.1 Asia Plasma Fractionation Revenue by Application (2021-2032)
- 11.2.2 Asia Plasma Fractionation Sales by Application (2021-2032)
- 11.2.3 Asia Plasma Fractionation Price by Application (2021-2032)
- 11.3 Asia Plasma Fractionation Market Size by Country
- 11.3.1 Asia Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Plasma Fractionation Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Plasma Fractionation Market Size by Type
- 12.1.1 SAMEA Plasma Fractionation Revenue by Type (2021-2032)
- 12.1.2 SAMEA Plasma Fractionation Sales by Type (2021-2032)
- 12.1.3 SAMEA Plasma Fractionation Price by Type (2021-2032)
- 12.2 SAMEA Plasma Fractionation Market Size by Application
- 12.2.1 SAMEA Plasma Fractionation Revenue by Application (2021-2032)
- 12.2.2 SAMEA Plasma Fractionation Sales by Application (2021-2032)
- 12.2.3 SAMEA Plasma Fractionation Price by Application (2021-2032)
- 12.3 SAMEA Plasma Fractionation Market Size by Country
- 12.3.1 SAMEA Plasma Fractionation Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Plasma Fractionation Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Plasma Fractionation Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Plasma Fractionation Value Chain Analysis
- 13.1.1 Plasma Fractionation Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Plasma Fractionation Production Mode & Process
- 13.2 Plasma Fractionation Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Plasma Fractionation Distributors
- 13.2.3 Plasma Fractionation Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst